AD-VEGF-C-treated and VEGF-C156S-treated mice both had significantly highernumbers of CD11c-positive dendritic cells compared to DSS-treated mice (32.0±1.9vs 18.8±2.2; P=0.004, and 32.6±2.0 vs 22.4±1.7;P=0.002, respectively) (Supplementary Figure S2B and C). The gene discussed is VEGFC; the disease is Alzheimer disease.